Clinical Trial Update: Bone Loss in Melanoma Survivors Receiving Immunotherapy

View source ↗

Summary

A terminated clinical trial from MD Anderson Cancer Center studied bone loss in melanoma survivors treated with immunotherapy, including patients with stage III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Status: TERMINATED